Ingevity reported a strong first quarter in 2021, with net sales up 11.1% to $320.3 million and net income up 7.5% to $48.7 million. Adjusted EBITDA increased by 14.3% to $105.4 million. The company has increased its fiscal year 2021 guidance for sales and adjusted EBITDA.
Net sales of $320.3 million were up 11.1%.
Net income of $48.7 million was up 7.5%; net income margin was 15.2%, down 50 basis points.
Adjusted EBITDA of $105.4 million was up 14.3%; adjusted EBITDA margin of 32.9%, up 90 basis points.
Company increases fiscal year 2021 guidance for sales to between $1.275 billion and $1.325 billion and adjusted EBITDA to between $410 million and $430 million
Ingevity has increased its fiscal year 2021 guidance for sales from between $1.25 billion and $1.30 billion to sales between $1.275 billion to $1.325 billion, and for adjusted EBITDA from between $400 million and $420 million to adjusted EBITDA between $410 million to $430 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance